Minerva Neurosciences (NERV) Assets (2013 - 2026)

Minerva Neurosciences (NERV) has 14 years of Assets data on file, last reported at $94.0 million in Q1 2026.

• Quarterly Assets rose 186.68% year-over-year to $94.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $94.0 million (up 186.68% YoY) and the FY2025 annual result came in at $98.0 million, up 163.76% from the prior year.
• Assets eased to $94.0 million in Q1 2026, from $98.0 million in the prior quarter.
• In the past five years, Assets ranged from a high of $98.0 million in Q4 2025 to a low of $28.1 million in Q3 2025.
• A 5-year average of $55.8 million and a median of $55.1 million in 2022 frame the typical range for Assets.
• Annual changes were most pronounced in 2022 — Assets sank 38.75% — and 2026, when it soared 186.68%.
• Tracing NERV's Assets over 5 years: stood at $55.1 million in 2022, then rose by 3.29% to $56.9 million in 2023, then plunged by 34.72% to $37.1 million in 2024, then jumped by 163.76% to $98.0 million in 2025, then slipped by 4.02% to $94.0 million in 2026.
• The last three Assets figures came in at $94.0 million (Q1 2026), $98.0 million (Q4 2025), and $28.1 million (Q3 2025), per Business Quant data.